Gene Symbol | Gene ID | Gene Info |
---|---|---|
RORA
|
ENSG00000069667.11 | RAR related orphan receptor A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_60883775_60883968 | RORA | 869 | 0.664381 | -0.89 | 1.5e-03 | Click! |
chr15_60885332_60885500 | RORA | 91 | 0.977330 | -0.79 | 1.0e-02 | Click! |
chr15_60936882_60937033 | RORA | 17295 | 0.206626 | 0.74 | 2.3e-02 | Click! |
chr15_60884114_60884267 | RORA | 550 | 0.812497 | -0.73 | 2.4e-02 | Click! |
chr15_60902634_60902785 | RORA | 16934 | 0.216934 | -0.70 | 3.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_50611338_50611602 | 0.62 |
RP3-405J10.4 |
|
1917 |
0.22 |
chr9_18437920_18438071 | 0.57 |
ADAMTSL1 |
ADAMTS-like 1 |
35897 |
0.23 |
chr17_39217082_39217233 | 0.56 |
KRTAP2-3 |
keratin associated protein 2-3 |
813 |
0.31 |
chr9_89990192_89990343 | 0.56 |
ENSG00000212421 |
. |
114902 |
0.06 |
chr17_73872544_73873300 | 0.54 |
TRIM47 |
tripartite motif containing 47 |
423 |
0.43 |
chr18_24196978_24197129 | 0.54 |
KCTD1 |
potassium channel tetramerization domain containing 1 |
12153 |
0.2 |
chr9_83646594_83646895 | 0.54 |
ENSG00000221581 |
. |
297500 |
0.01 |
chr3_149738658_149738809 | 0.54 |
PFN2 |
profilin 2 |
1865 |
0.34 |
chr6_140382856_140383007 | 0.53 |
ENSG00000252107 |
. |
96900 |
0.09 |
chr5_150025102_150025253 | 0.53 |
SYNPO |
synaptopodin |
4937 |
0.16 |
chr2_9571047_9571198 | 0.53 |
CPSF3 |
cleavage and polyadenylation specific factor 3, 73kDa |
7109 |
0.19 |
chr10_115234705_115234856 | 0.52 |
HABP2 |
hyaluronan binding protein 2 |
75816 |
0.11 |
chr5_53683581_53683732 | 0.52 |
HSPB3 |
heat shock 27kDa protein 3 |
67789 |
0.12 |
chr1_68403039_68403338 | 0.52 |
GNG12-AS1 |
GNG12 antisense RNA 1 |
17900 |
0.24 |
chr6_57129918_57130069 | 0.51 |
RAB23 |
RAB23, member RAS oncogene family |
42915 |
0.15 |
chr2_9777860_9778099 | 0.51 |
YWHAQ |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta |
6836 |
0.21 |
chr14_86031688_86031839 | 0.51 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
35191 |
0.2 |
chr6_37423751_37423902 | 0.50 |
CMTR1 |
cap methyltransferase 1 |
19269 |
0.19 |
chr1_20390393_20390544 | 0.50 |
PLA2G5 |
phospholipase A2, group V |
6233 |
0.2 |
chr2_19323725_19323876 | 0.49 |
ENSG00000266738 |
. |
224390 |
0.02 |
chr1_64991178_64991359 | 0.49 |
ENSG00000264470 |
. |
54262 |
0.14 |
chr2_33294539_33294812 | 0.49 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
64798 |
0.12 |
chr4_96028162_96028313 | 0.48 |
BMPR1B |
bone morphogenetic protein receptor, type IB |
2731 |
0.44 |
chr5_33612837_33612988 | 0.48 |
TARS |
threonyl-tRNA synthetase |
171425 |
0.03 |
chr8_117600503_117600654 | 0.48 |
EIF3H |
eukaryotic translation initiation factor 3, subunit H |
167445 |
0.03 |
chr16_66416650_66416801 | 0.47 |
CDH5 |
cadherin 5, type 2 (vascular endothelium) |
3597 |
0.24 |
chr11_9191471_9191622 | 0.47 |
DENND5A |
DENN/MADD domain containing 5A |
2246 |
0.32 |
chr16_65151739_65151890 | 0.47 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
4019 |
0.39 |
chr5_145356260_145356548 | 0.46 |
SH3RF2 |
SH3 domain containing ring finger 2 |
38964 |
0.18 |
chr3_187952552_187952703 | 0.46 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
5025 |
0.29 |
chr18_8213240_8213391 | 0.46 |
ENSG00000212067 |
. |
13868 |
0.23 |
chr12_69927570_69927949 | 0.46 |
FRS2 |
fibroblast growth factor receptor substrate 2 |
3156 |
0.27 |
chr3_66033537_66033688 | 0.45 |
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
9387 |
0.23 |
chr9_6567455_6567606 | 0.45 |
ENSG00000252110 |
. |
1105 |
0.53 |
chr20_10829555_10829706 | 0.45 |
RP11-103J8.1 |
|
53302 |
0.17 |
chr19_17422479_17422790 | 0.45 |
ABHD8 |
abhydrolase domain containing 8 |
1589 |
0.16 |
chr8_119065102_119065253 | 0.44 |
EXT1 |
exostosin glycosyltransferase 1 |
57476 |
0.17 |
chr3_50285847_50286499 | 0.43 |
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
1847 |
0.19 |
chr19_2149731_2150754 | 0.43 |
AP3D1 |
adaptor-related protein complex 3, delta 1 subunit |
1297 |
0.32 |
chr11_12821990_12822259 | 0.43 |
RP11-47J17.3 |
|
23090 |
0.19 |
chr10_79743394_79743545 | 0.43 |
POLR3A |
polymerase (RNA) III (DNA directed) polypeptide A, 155kDa |
45834 |
0.12 |
chr3_138188194_138188345 | 0.43 |
CEP70 |
centrosomal protein 70kDa |
30753 |
0.18 |
chr13_76345505_76345656 | 0.43 |
LMO7 |
LIM domain 7 |
10783 |
0.26 |
chr3_114161428_114161579 | 0.42 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
12027 |
0.25 |
chr1_203503489_203503640 | 0.42 |
OPTC |
opticin |
38466 |
0.16 |
chr6_41065063_41065214 | 0.42 |
OARD1 |
O-acyl-ADP-ribose deacylase 1 |
359 |
0.81 |
chr20_60735818_60735969 | 0.42 |
SS18L1 |
synovial sarcoma translocation gene on chromosome 18-like 1 |
2049 |
0.25 |
chr1_118229559_118229710 | 0.42 |
ENSG00000212266 |
. |
1730 |
0.47 |
chr3_106927449_106927600 | 0.42 |
ENSG00000220989 |
. |
156505 |
0.04 |
chr1_85805849_85806000 | 0.42 |
ENSG00000264380 |
. |
55631 |
0.09 |
chr15_85888485_85888636 | 0.42 |
AKAP13 |
A kinase (PRKA) anchor protein 13 |
35258 |
0.15 |
chr8_123868137_123868288 | 0.42 |
ZHX2 |
zinc fingers and homeoboxes 2 |
7412 |
0.2 |
chr16_69074448_69074599 | 0.41 |
ENSG00000202497 |
. |
33465 |
0.14 |
chr5_138397564_138397715 | 0.41 |
SIL1 |
SIL1 nucleotide exchange factor |
19268 |
0.18 |
chr15_74232933_74233272 | 0.41 |
LOXL1-AS1 |
LOXL1 antisense RNA 1 |
12513 |
0.14 |
chr12_26148588_26148739 | 0.41 |
RASSF8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
726 |
0.74 |
chr4_160281542_160281693 | 0.41 |
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
10237 |
0.27 |
chr17_36620738_36620994 | 0.41 |
ARHGAP23 |
Rho GTPase activating protein 23 |
7222 |
0.17 |
chr4_73836894_73837045 | 0.40 |
ENSG00000252955 |
. |
6074 |
0.28 |
chr13_33700338_33700489 | 0.40 |
STARD13-IT1 |
STARD13 intronic transcript 1 (non-protein coding) |
38133 |
0.17 |
chr8_8522351_8522502 | 0.40 |
ENSG00000264445 |
. |
31452 |
0.18 |
chr5_152869678_152869829 | 0.40 |
GRIA1 |
glutamate receptor, ionotropic, AMPA 1 |
353 |
0.94 |
chr7_151200413_151200564 | 0.40 |
RHEB |
Ras homolog enriched in brain |
14667 |
0.16 |
chr2_150451982_150452133 | 0.40 |
MMADHC |
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria |
7727 |
0.21 |
chr2_74004592_74004743 | 0.40 |
DUSP11 |
dual specificity phosphatase 11 (RNA/RNP complex 1-interacting) |
2428 |
0.25 |
chr17_65214980_65215131 | 0.40 |
RP11-401F2.4 |
|
5364 |
0.17 |
chr12_4140465_4141124 | 0.39 |
RP11-664D1.1 |
|
126408 |
0.05 |
chr6_143591799_143591950 | 0.39 |
AIG1 |
androgen-induced 1 |
144487 |
0.04 |
chr8_124656767_124656918 | 0.39 |
KLHL38 |
kelch-like family member 38 |
8348 |
0.2 |
chr16_4263907_4264209 | 0.39 |
SRL |
sarcalumenin |
25686 |
0.16 |
chr1_178209193_178209344 | 0.39 |
RASAL2 |
RAS protein activator like 2 |
101338 |
0.08 |
chr14_96556907_96557058 | 0.39 |
C14orf132 |
chromosome 14 open reading frame 132 |
386 |
0.88 |
chr2_46542032_46542183 | 0.38 |
EPAS1 |
endothelial PAS domain protein 1 |
17566 |
0.25 |
chr4_15454262_15454413 | 0.38 |
CC2D2A |
coiled-coil and C2 domain containing 2A |
17152 |
0.16 |
chr5_112417198_112417349 | 0.38 |
DCP2 |
decapping mRNA 2 |
104794 |
0.06 |
chr10_114846149_114846300 | 0.38 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
57455 |
0.15 |
chr6_76147282_76147433 | 0.38 |
ENSG00000263533 |
. |
9234 |
0.18 |
chr11_63440539_63440690 | 0.38 |
ATL3 |
atlastin GTPase 3 |
1221 |
0.4 |
chr16_82787297_82787448 | 0.38 |
RP11-22H5.2 |
|
19552 |
0.24 |
chr14_25580776_25580927 | 0.38 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
61348 |
0.15 |
chr11_118491249_118491656 | 0.38 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
13094 |
0.11 |
chr1_93405805_93405956 | 0.38 |
FAM69A |
family with sequence similarity 69, member A |
21177 |
0.12 |
chr1_159567510_159567661 | 0.38 |
APCS |
amyloid P component, serum |
9970 |
0.22 |
chr3_192603097_192603248 | 0.38 |
MB21D2 |
Mab-21 domain containing 2 |
32778 |
0.23 |
chr14_100275563_100275795 | 0.38 |
EML1 |
echinoderm microtubule associated protein like 1 |
109 |
0.98 |
chr20_13010496_13010647 | 0.37 |
SPTLC3 |
serine palmitoyltransferase, long chain base subunit 3 |
20574 |
0.28 |
chr3_54897591_54897742 | 0.37 |
CACNA2D3-AS1 |
CACNA2D3 antisense RNA 1 |
37616 |
0.21 |
chr6_140247827_140247978 | 0.37 |
ENSG00000252107 |
. |
231929 |
0.02 |
chr11_91863154_91863305 | 0.37 |
FAT3 |
FAT atypical cadherin 3 |
222033 |
0.02 |
chr11_100746918_100747069 | 0.37 |
ENSG00000200047 |
. |
36632 |
0.15 |
chr2_190700976_190701127 | 0.37 |
PMS1 |
PMS1 postmeiotic segregation increased 1 (S. cerevisiae) |
18198 |
0.15 |
chr15_62737179_62737605 | 0.37 |
TLN2 |
talin 2 |
116172 |
0.06 |
chr13_32368184_32368335 | 0.37 |
RXFP2 |
relaxin/insulin-like family peptide receptor 2 |
54580 |
0.17 |
chr5_102808188_102808485 | 0.36 |
NUDT12 |
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
90154 |
0.1 |
chr5_101963356_101963507 | 0.36 |
RP11-58B2.1 |
|
122458 |
0.06 |
chr19_48991020_48991171 | 0.36 |
CYTH2 |
cytohesin 2 |
15486 |
0.09 |
chr3_189428781_189428932 | 0.36 |
TP63 |
tumor protein p63 |
78593 |
0.11 |
chr10_60766507_60766658 | 0.36 |
ENSG00000252076 |
. |
137638 |
0.05 |
chr22_40998121_40998272 | 0.36 |
MKL1 |
megakaryoblastic leukemia (translocation) 1 |
34493 |
0.16 |
chr16_83437863_83438014 | 0.36 |
ENSG00000222299 |
. |
3718 |
0.27 |
chr7_34082557_34082708 | 0.36 |
BMPER |
BMP binding endothelial regulator |
137487 |
0.05 |
chr8_96653162_96653313 | 0.36 |
ENSG00000223297 |
. |
37906 |
0.19 |
chr1_12483776_12483927 | 0.35 |
VPS13D |
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
13927 |
0.23 |
chr2_205370374_205370525 | 0.35 |
PARD3B |
par-3 family cell polarity regulator beta |
40067 |
0.23 |
chr21_47480957_47481280 | 0.35 |
AP001471.1 |
|
36326 |
0.12 |
chr10_71567463_71567614 | 0.35 |
ENSG00000222631 |
. |
4913 |
0.22 |
chr8_69766358_69766509 | 0.35 |
ENSG00000239184 |
. |
158555 |
0.04 |
chr4_54643319_54643470 | 0.35 |
LNX1 |
ligand of numb-protein X 1, E3 ubiquitin protein ligase |
75822 |
0.1 |
chr18_43209000_43209203 | 0.35 |
SLC14A2 |
solute carrier family 14 (urea transporter), member 2 |
14335 |
0.2 |
chr9_111799017_111799168 | 0.35 |
ENSG00000199331 |
. |
5675 |
0.16 |
chr3_55208193_55208344 | 0.35 |
LRTM1 |
leucine-rich repeats and transmembrane domains 1 |
207153 |
0.03 |
chr2_153370502_153370653 | 0.35 |
FMNL2 |
formin-like 2 |
105515 |
0.08 |
chr6_35364753_35364904 | 0.35 |
PPARD |
peroxisome proliferator-activated receptor delta |
54426 |
0.1 |
chr10_114807131_114807282 | 0.35 |
RP11-57H14.2 |
|
95572 |
0.08 |
chr9_72664551_72664702 | 0.35 |
MAMDC2 |
MAM domain containing 2 |
6129 |
0.26 |
chr14_93701710_93701861 | 0.35 |
UBR7 |
ubiquitin protein ligase E3 component n-recognin 7 (putative) |
16758 |
0.14 |
chr11_116705965_116706733 | 0.35 |
APOA1-AS |
APOA1 antisense RNA |
484 |
0.63 |
chr10_128087058_128087209 | 0.35 |
ADAM12 |
ADAM metallopeptidase domain 12 |
10109 |
0.27 |
chr11_102048059_102048210 | 0.35 |
YAP1 |
Yes-associated protein 1 |
8678 |
0.21 |
chr3_189491567_189491718 | 0.35 |
TP63 |
tumor protein p63 |
15807 |
0.26 |
chr10_98574486_98574637 | 0.34 |
ENSG00000207976 |
. |
13960 |
0.18 |
chr14_89302209_89302360 | 0.34 |
ENSG00000207342 |
. |
4225 |
0.2 |
chr1_201679077_201679228 | 0.34 |
ENSG00000264802 |
. |
9484 |
0.13 |
chr2_43152776_43153425 | 0.34 |
HAAO |
3-hydroxyanthranilate 3,4-dioxygenase |
133368 |
0.05 |
chr7_47803470_47803621 | 0.34 |
LINC00525 |
long intergenic non-protein coding RNA 525 |
598 |
0.78 |
chr18_8231250_8231401 | 0.34 |
ENSG00000212067 |
. |
4142 |
0.29 |
chr10_79291019_79291170 | 0.34 |
ENSG00000199592 |
. |
55713 |
0.15 |
chr9_13939488_13939639 | 0.34 |
NFIB |
nuclear factor I/B |
241228 |
0.02 |
chr8_29368707_29368858 | 0.34 |
RP4-676L2.1 |
|
158095 |
0.04 |
chr15_48751523_48751674 | 0.34 |
DUT |
deoxyuridine triphosphatase |
126995 |
0.05 |
chrX_11456077_11456228 | 0.34 |
ARHGAP6 |
Rho GTPase activating protein 6 |
10259 |
0.3 |
chr8_118990982_118991133 | 0.34 |
EXT1 |
exostosin glycosyltransferase 1 |
131596 |
0.06 |
chr9_100528747_100528898 | 0.34 |
ENSG00000266608 |
. |
66306 |
0.09 |
chr5_34598742_34598893 | 0.34 |
RAI14 |
retinoic acid induced 14 |
57525 |
0.14 |
chr14_56381140_56381291 | 0.34 |
ENSG00000212522 |
. |
153946 |
0.04 |
chr20_36688656_36688807 | 0.34 |
ENSG00000252791 |
. |
7583 |
0.16 |
chr11_128077291_128077590 | 0.33 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
297849 |
0.01 |
chr5_64337655_64337871 | 0.33 |
ENSG00000207439 |
. |
81433 |
0.11 |
chr7_32201662_32201813 | 0.33 |
PDE1C |
phosphodiesterase 1C, calmodulin-dependent 70kDa |
90689 |
0.1 |
chr8_8153749_8153900 | 0.33 |
ALG1L13P |
asparagine-linked glycosylation 1-like 13, pseudogene |
54891 |
0.11 |
chr7_127410750_127410901 | 0.33 |
SND1 |
staphylococcal nuclease and tudor domain containing 1 |
117140 |
0.05 |
chr13_60713678_60713829 | 0.33 |
DIAPH3-AS2 |
DIAPH3 antisense RNA 2 |
5079 |
0.24 |
chr13_49672995_49673224 | 0.33 |
ENSG00000199788 |
. |
3582 |
0.27 |
chr1_201423553_201423704 | 0.33 |
PHLDA3 |
pleckstrin homology-like domain, family A, member 3 |
14684 |
0.15 |
chr2_20793453_20793604 | 0.33 |
HS1BP3-IT1 |
HS1BP3 intronic transcript 1 (non-protein coding) |
1220 |
0.52 |
chr7_143190324_143190475 | 0.33 |
TAS2R41 |
taste receptor, type 2, member 41 |
15433 |
0.16 |
chr11_33713061_33713264 | 0.33 |
RP4-541C22.5 |
|
5085 |
0.19 |
chr8_89130096_89130247 | 0.33 |
CTB-118P15.2 |
|
143778 |
0.05 |
chr10_33631255_33631406 | 0.33 |
NRP1 |
neuropilin 1 |
6140 |
0.29 |
chr10_35620918_35621160 | 0.33 |
RP11-324I22.4 |
|
4290 |
0.22 |
chr4_95330317_95330468 | 0.33 |
PDLIM5 |
PDZ and LIM domain 5 |
42645 |
0.19 |
chr2_175659979_175660130 | 0.33 |
CHRNA1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
30854 |
0.19 |
chr4_157897574_157897725 | 0.33 |
PDGFC |
platelet derived growth factor C |
5103 |
0.24 |
chr13_42423265_42423416 | 0.33 |
ENSG00000241406 |
. |
41527 |
0.17 |
chr16_65347210_65347398 | 0.33 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
191036 |
0.03 |
chrY_28466108_28466259 | 0.32 |
ENSG00000252948 |
. |
40953 |
0.2 |
chr5_10453332_10453562 | 0.32 |
ROPN1L |
rhophilin associated tail protein 1-like |
11459 |
0.14 |
chr16_73102131_73102454 | 0.32 |
ZFHX3 |
zinc finger homeobox 3 |
8695 |
0.24 |
chr19_3374038_3374830 | 0.32 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
7850 |
0.19 |
chr18_25763676_25763827 | 0.32 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
6341 |
0.35 |
chr6_11188200_11188351 | 0.32 |
RP3-510L9.1 |
|
14590 |
0.2 |
chr16_53728728_53728879 | 0.32 |
RPGRIP1L |
RPGRIP1-like |
8919 |
0.23 |
chr5_14191108_14191422 | 0.32 |
TRIO |
trio Rho guanine nucleotide exchange factor |
7358 |
0.33 |
chr3_159444348_159444499 | 0.32 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
37079 |
0.16 |
chr9_89021972_89022123 | 0.32 |
ENSG00000222293 |
. |
15996 |
0.24 |
chr20_43683503_43683886 | 0.32 |
KCNS1 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 |
46056 |
0.1 |
chr16_49677699_49678055 | 0.32 |
ZNF423 |
zinc finger protein 423 |
3114 |
0.33 |
chr3_123588793_123588944 | 0.32 |
MYLK |
myosin light chain kinase |
14281 |
0.22 |
chr2_236342022_236342173 | 0.32 |
AGAP1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
60636 |
0.13 |
chr2_74373621_74374624 | 0.32 |
BOLA3 |
bolA family member 3 |
910 |
0.35 |
chr11_12191424_12191575 | 0.32 |
MICAL2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
7796 |
0.27 |
chr7_41950835_41950986 | 0.32 |
AC005027.3 |
|
205977 |
0.03 |
chr6_160457258_160457573 | 0.32 |
AIRN |
antisense of IGF2R non-protein coding RNA |
28719 |
0.19 |
chr1_52434488_52434639 | 0.32 |
ENSG00000200839 |
. |
4519 |
0.15 |
chr7_94050761_94050912 | 0.32 |
COL1A2 |
collagen, type I, alpha 2 |
26963 |
0.22 |
chr5_88027740_88027966 | 0.32 |
CTC-467M3.2 |
|
39385 |
0.16 |
chr1_18201641_18201961 | 0.32 |
ACTL8 |
actin-like 8 |
119993 |
0.06 |
chr10_33274428_33274757 | 0.31 |
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
6799 |
0.27 |
chr3_78968042_78968193 | 0.31 |
ENSG00000240964 |
. |
19325 |
0.28 |
chr19_1168901_1169806 | 0.31 |
SBNO2 |
strawberry notch homolog 2 (Drosophila) |
411 |
0.76 |
chr21_30143536_30143687 | 0.31 |
ENSG00000251894 |
. |
28081 |
0.23 |
chr4_150085945_150086096 | 0.31 |
ENSG00000239168 |
. |
173235 |
0.04 |
chr8_32201421_32201572 | 0.31 |
ENSG00000200246 |
. |
87484 |
0.09 |
chr12_47629984_47630533 | 0.31 |
PCED1B |
PC-esterase domain containing 1B |
12930 |
0.21 |
chr2_110756993_110757205 | 0.31 |
ENSG00000265682 |
. |
70520 |
0.1 |
chr3_187453619_187453770 | 0.31 |
BCL6 |
B-cell CLL/lymphoma 6 |
663 |
0.73 |
chr2_113075036_113075187 | 0.31 |
ZC3H6 |
zinc finger CCCH-type containing 6 |
41933 |
0.14 |
chr16_72289972_72290233 | 0.31 |
PMFBP1 |
polyamine modulated factor 1 binding protein 1 |
79325 |
0.09 |
chr1_225836875_225837026 | 0.31 |
ENAH |
enabled homolog (Drosophila) |
3468 |
0.27 |
chr1_46379565_46379716 | 0.31 |
MAST2 |
microtubule associated serine/threonine kinase 2 |
380 |
0.91 |
chr4_174267247_174267398 | 0.31 |
HMGB2 |
high mobility group box 2 |
11046 |
0.13 |
chrY_27544696_27544847 | 0.31 |
ENSG00000272042 |
. |
60283 |
0.14 |
chr5_95571294_95571445 | 0.31 |
ENSG00000206997 |
. |
25438 |
0.24 |
chr11_34324437_34324812 | 0.31 |
ABTB2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
54178 |
0.15 |
chr7_90012529_90012680 | 0.31 |
CLDN12 |
claudin 12 |
431 |
0.85 |
chr6_74783073_74783224 | 0.31 |
RP11-553A21.3 |
|
377294 |
0.01 |
chr12_2723257_2723602 | 0.31 |
CACNA1C-AS3 |
CACNA1C antisense RNA 3 |
6823 |
0.24 |
chr15_99440684_99440835 | 0.31 |
RP11-654A16.1 |
|
3995 |
0.25 |
chr16_87120081_87120232 | 0.31 |
RP11-899L11.3 |
|
129365 |
0.05 |
chr13_102263996_102264147 | 0.31 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
13576 |
0.3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.3 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.2 | GO:0001743 | optic placode formation(GO:0001743) |
0.0 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.3 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.0 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.2 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.1 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.3 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.2 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.0 | 0.1 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0034651 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.0 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.0 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.0 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.1 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.0 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.0 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.0 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.0 | 0.0 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.3 | GO:0010171 | body morphogenesis(GO:0010171) |
0.0 | 0.1 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.0 | GO:0072007 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.1 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.0 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.0 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.0 | 0.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.2 | GO:0060415 | muscle tissue morphogenesis(GO:0060415) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.0 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:1901796 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) smooth muscle adaptation(GO:0014805) inflammatory response to wounding(GO:0090594) |
0.0 | 0.0 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 0.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.0 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.0 | 0.1 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.0 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.0 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.2 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.0 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.0 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 1.3 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.0 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.7 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.4 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.8 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.2 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 1.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 1.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |